LGM Pharma - About Us

LGM Pharma is an innovation-driven API company, involved in distribution of quality cGMP pharma ingredients to leading pharmaceutical companies.

Our Capabilities

We specialize in supplying our customers with a wide range of APIs supported by integrated technical capabilities and access to complete regulatory DMF documentation, suitable for various R&D stages through commercial formulation production.

Our products originate from our API manufacturing partner sites who are approved by the leading health authorities, such as the US-FDA, EDQM, TGA, UK-MHRA etc. Some of the APIs that we supply are manufactured via non-infringing processes which would be suitable for Paragraph IV challenges / early launches in regulated markets.

Through competent assistance by our sales department, complete technical & regulatory capabilities and fast delivery of high quality ingredients at competitive prices, LGM has become a preferred API supply source.

Our Mission

Our mission is to deliver premium quality APIs and
outstanding services to our clients.

Our industry experience enables us to support our clients
throughout the entire pathway of drug development, from
discovery through commercial production.

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service